These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 17071739)
1. Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome. Shaw EA; Colville D; Wang YY; Zhang KW; Dagher H; Fassett R; Guymer R; Savige J Nephrol Dial Transplant; 2007 Jan; 22(1):104-8. PubMed ID: 17071739 [TBL] [Abstract][Full Text] [Related]
2. The retinal "lozenge" or "dull macular reflex" in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure. Colville D; Wang YY; Tan R; Savige J Br J Ophthalmol; 2009 Mar; 93(3):383-6. PubMed ID: 19019929 [TBL] [Abstract][Full Text] [Related]
3. Absence of ocular manifestations in autosomal dominant Alport syndrome associated with haematological abnormalties. Colville D; Wang YY; Jamieson R; Collins F; Hood J; Savige J Ophthalmic Genet; 2000 Dec; 21(4):217-25. PubMed ID: 11135492 [TBL] [Abstract][Full Text] [Related]
4. Alport syndrome. Molecular genetic aspects. Hertz JM Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970 [TBL] [Abstract][Full Text] [Related]
5. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families. Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941 [TBL] [Abstract][Full Text] [Related]
6. Ocular features in Alport syndrome: pathogenesis and clinical significance. Savige J; Sheth S; Leys A; Nicholson A; Mack HG; Colville D Clin J Am Soc Nephrol; 2015 Apr; 10(4):703-9. PubMed ID: 25649157 [TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241 [TBL] [Abstract][Full Text] [Related]
9. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome]. Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607 [TBL] [Abstract][Full Text] [Related]
10. [Clinical and genetic features of the Alport 'syndromes']. Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804 [TBL] [Abstract][Full Text] [Related]
12. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect]. Maziers N; Dahan K; Pirson Y Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome. Dagher H; Buzza M; Colville D; Jones C; Powell H; Fassett R; Wilson D; Agar J; Savige J Am J Kidney Dis; 2001 Dec; 38(6):1217-28. PubMed ID: 11728953 [TBL] [Abstract][Full Text] [Related]
14. Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome. Dagher H; Yan Wang Y; Fassett R; Savige J Hum Mutat; 2002 Oct; 20(4):321-2. PubMed ID: 12325029 [TBL] [Abstract][Full Text] [Related]
15. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities. Wilson JC; Yoon HS; Walker RJ; Eccles MR Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342 [TBL] [Abstract][Full Text] [Related]
16. The dot-and-fleck retinopathy of X linked Alport syndrome is independent of complement factor H (CFH) gene polymorphisms. Liu J; Colville D; Wang YY; Baird PN; Guymer RH; Savige J Br J Ophthalmol; 2009 Mar; 93(3):379-82. PubMed ID: 19019939 [TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular diagnosis of Alport syndrome. Kashtan CE Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415 [TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic features in autosomal recessive and X-linked Alport syndrome. Wang Y; Sivakumar V; Mohammad M; Colville D; Storey H; Flinter F; Dagher H; Savige J Pediatr Nephrol; 2014 Mar; 29(3):391-6. PubMed ID: 24178893 [TBL] [Abstract][Full Text] [Related]
19. The use of ocular abnormalities to diagnose X-linked Alport syndrome in children. Zhang KW; Colville D; Tan R; Jones C; Alexander SI; Fletcher J; Savige J Pediatr Nephrol; 2008 Aug; 23(8):1245-50. PubMed ID: 18343956 [TBL] [Abstract][Full Text] [Related]
20. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]